Wang DL, Gu DY, Huang HY, Xu Z, Chen JF. Irinotecan-involved regimens for advanced gastric cancer: A pooled-analysis of clinical trials. World J Gastroenterol 2010; 16(46): 5889-5894 [PMID: 21155012 DOI: 10.3748/wjg.v16.i46.5889]
Corresponding Author of This Article
Dr. Jin-Fei Chen, Department of Oncology, Affiliated Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China. jinfeichen@sohu.com
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/